

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | complement activation, alternative pathway (GO:0006957) | 9.19374655 |
| 2 | regulation of protein activation cascade (GO:2000257) | 8.51394831 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 8.38890675 |
| 4 | L-phenylalanine catabolic process (GO:0006559) | 8.38890675 |
| 5 | exogenous drug catabolic process (GO:0042738) | 8.36123412 |
| 6 | omega-hydroxylase P450 pathway (GO:0097267) | 8.33734267 |
| 7 | epoxygenase P450 pathway (GO:0019373) | 8.19264836 |
| 8 | drug catabolic process (GO:0042737) | 8.16143923 |
| 9 | regulation of complement activation (GO:0030449) | 8.00330913 |
| 10 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.77218757 |
| 11 | L-phenylalanine metabolic process (GO:0006558) | 7.77218757 |
| 12 | glyoxylate metabolic process (GO:0046487) | 7.30204421 |
| 13 | opsonization (GO:0008228) | 6.93542485 |
| 14 | regulation of fibrinolysis (GO:0051917) | 6.85180360 |
| 15 | negative regulation of fibrinolysis (GO:0051918) | 6.74751518 |
| 16 | protein carboxylation (GO:0018214) | 6.44861778 |
| 17 | peptidyl-glutamic acid carboxylation (GO:0017187) | 6.44861778 |
| 18 | acute-phase response (GO:0006953) | 6.34329330 |
| 19 | ethanol oxidation (GO:0006069) | 6.08236688 |
| 20 | aromatic amino acid family catabolic process (GO:0009074) | 6.04542696 |
| 21 | drug metabolic process (GO:0017144) | 5.96678629 |
| 22 | urea metabolic process (GO:0019627) | 5.90453064 |
| 23 | oxidative demethylation (GO:0070989) | 5.85701116 |
| 24 | serine family amino acid catabolic process (GO:0009071) | 5.81364256 |
| 25 | complement activation (GO:0006956) | 5.66165616 |
| 26 | fibrinolysis (GO:0042730) | 5.62364436 |
| 27 | bile acid biosynthetic process (GO:0006699) | 5.59824374 |
| 28 | complement activation, classical pathway (GO:0006958) | 5.59248971 |
| 29 | protein activation cascade (GO:0072376) | 5.59183853 |
| 30 | blood coagulation, intrinsic pathway (GO:0007597) | 5.46930179 |
| 31 | cellular glucuronidation (GO:0052695) | 5.43588990 |
| 32 | nitrogen cycle metabolic process (GO:0071941) | 5.36973863 |
| 33 | regulation of triglyceride catabolic process (GO:0010896) | 5.21195679 |
| 34 | cytolysis (GO:0019835) | 5.19294179 |
| 35 | glycine metabolic process (GO:0006544) | 5.18861059 |
| 36 | negative regulation of protein activation cascade (GO:2000258) | 5.18211685 |
| 37 | uronic acid metabolic process (GO:0006063) | 5.16207498 |
| 38 | glucuronate metabolic process (GO:0019585) | 5.16207498 |
| 39 | bile acid metabolic process (GO:0008206) | 5.14812481 |
| 40 | regulation of humoral immune response (GO:0002920) | 5.13801467 |
| 41 | ethanol metabolic process (GO:0006067) | 5.09631335 |
| 42 | S-adenosylmethionine metabolic process (GO:0046500) | 5.04337697 |
| 43 | tyrosine metabolic process (GO:0006570) | 5.03047168 |
| 44 | phenylpropanoid metabolic process (GO:0009698) | 5.00512882 |
| 45 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.97576655 |
| 46 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 4.91997451 |
| 47 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 4.91997451 |
| 48 | urea cycle (GO:0000050) | 4.90585789 |
| 49 | regulation of plasminogen activation (GO:0010755) | 4.79803913 |
| 50 | acute inflammatory response (GO:0002526) | 4.57369867 |
| 51 | negative regulation of sterol transport (GO:0032372) | 4.46487664 |
| 52 | negative regulation of cholesterol transport (GO:0032375) | 4.46487664 |
| 53 | amino-acid betaine metabolic process (GO:0006577) | 4.40448385 |
| 54 | response to mercury ion (GO:0046689) | 4.39058952 |
| 55 | bile acid and bile salt transport (GO:0015721) | 4.30646441 |
| 56 | negative regulation of hemostasis (GO:1900047) | 4.28242246 |
| 57 | negative regulation of blood coagulation (GO:0030195) | 4.28242246 |
| 58 | acylglycerol homeostasis (GO:0055090) | 4.18810622 |
| 59 | triglyceride homeostasis (GO:0070328) | 4.18810622 |
| 60 | imidazole-containing compound metabolic process (GO:0052803) | 4.15720071 |
| 61 | hormone catabolic process (GO:0042447) | 4.11567510 |
| 62 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.05989647 |
| 63 | negative regulation of complement activation (GO:0045916) | 4.03018846 |
| 64 | serine family amino acid metabolic process (GO:0009069) | 4.00323604 |
| 65 | aromatic amino acid family metabolic process (GO:0009072) | 3.97920254 |
| 66 | tryptophan catabolic process (GO:0006569) | 3.96233382 |
| 67 | indole-containing compound catabolic process (GO:0042436) | 3.96233382 |
| 68 | indolalkylamine catabolic process (GO:0046218) | 3.96233382 |
| 69 | negative regulation of wound healing (GO:0061045) | 3.95919928 |
| 70 | negative regulation of coagulation (GO:0050819) | 3.93488648 |
| 71 | glutamate metabolic process (GO:0006536) | 3.90914705 |
| 72 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.90520186 |
| 73 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.90520186 |
| 74 | flavonoid metabolic process (GO:0009812) | 3.89227469 |
| 75 | regulation of apoptotic cell clearance (GO:2000425) | 3.84012241 |
| 76 | alpha-amino acid catabolic process (GO:1901606) | 3.77478293 |
| 77 | intestinal cholesterol absorption (GO:0030299) | 3.75973171 |
| 78 | protein-lipid complex remodeling (GO:0034368) | 3.62061258 |
| 79 | macromolecular complex remodeling (GO:0034367) | 3.62061258 |
| 80 | plasma lipoprotein particle remodeling (GO:0034369) | 3.62061258 |
| 81 | regulation of acute inflammatory response (GO:0002673) | 3.61629826 |
| 82 | primary alcohol catabolic process (GO:0034310) | 3.60765438 |
| 83 | xenobiotic metabolic process (GO:0006805) | 3.52958896 |
| 84 | negative regulation of lipase activity (GO:0060192) | 3.48862670 |
| 85 | cholesterol efflux (GO:0033344) | 3.48763893 |
| 86 | coenzyme catabolic process (GO:0009109) | 3.48179984 |
| 87 | alkaloid metabolic process (GO:0009820) | 3.47294156 |
| 88 | arginine metabolic process (GO:0006525) | 3.43170061 |
| 89 | positive regulation of blood coagulation (GO:0030194) | 3.42487426 |
| 90 | positive regulation of hemostasis (GO:1900048) | 3.42487426 |
| 91 | tryptophan metabolic process (GO:0006568) | 3.42162047 |
| 92 | negative regulation of humoral immune response (GO:0002921) | 3.34009012 |
| 93 | heme transport (GO:0015886) | 3.33228547 |
| 94 | xenobiotic catabolic process (GO:0042178) | 3.27073268 |
| 95 | cofactor catabolic process (GO:0051187) | 3.26743052 |
| 96 | oxaloacetate metabolic process (GO:0006107) | 3.26611761 |
| 97 | cellular amino acid catabolic process (GO:0009063) | 3.25327934 |
| 98 | daunorubicin metabolic process (GO:0044597) | 3.24620825 |
| 99 | polyketide metabolic process (GO:0030638) | 3.24620825 |
| 100 | doxorubicin metabolic process (GO:0044598) | 3.24620825 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.73786597 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.46611056 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.33319712 |
| 4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.28965552 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.22939518 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.00081626 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.92716833 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.58600214 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.48016642 |
| 10 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.39523153 |
| 11 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.15827364 |
| 12 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.8698413 |
| 13 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.95577879 |
| 14 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.90180651 |
| 15 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.76339100 |
| 16 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.73694914 |
| 17 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.72811479 |
| 18 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.71589703 |
| 19 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.65131649 |
| 20 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.52318440 |
| 21 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.31767792 |
| 22 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.30619268 |
| 23 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.19023979 |
| 24 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.15842217 |
| 25 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.14769957 |
| 26 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.09457211 |
| 27 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.06754234 |
| 28 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.06415936 |
| 29 | CBP_21632823_ChIP-Seq_H3396_Human | 1.05889601 |
| 30 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.05601162 |
| 31 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.04301242 |
| 32 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.03925394 |
| 33 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.02175449 |
| 34 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.95644842 |
| 35 | GATA1_22025678_ChIP-Seq_K562_Human | 0.94950599 |
| 36 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.94657595 |
| 37 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.94625929 |
| 38 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.94440404 |
| 39 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.92313610 |
| 40 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.91269756 |
| 41 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.88865342 |
| 42 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.86940243 |
| 43 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.85156688 |
| 44 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.83087961 |
| 45 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.82962153 |
| 46 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.82818241 |
| 47 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.80985528 |
| 48 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.80352417 |
| 49 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.76586897 |
| 50 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.73510912 |
| 51 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.72940202 |
| 52 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.72557032 |
| 53 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.71825543 |
| 54 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.71338044 |
| 55 | NFYA_21822215_ChIP-Seq_K562_Human | 0.70731412 |
| 56 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.70505959 |
| 57 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.70296177 |
| 58 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.69010288 |
| 59 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.68796652 |
| 60 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.68647864 |
| 61 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.68630365 |
| 62 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.67364953 |
| 63 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.65584975 |
| 64 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.63780668 |
| 65 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.62027406 |
| 66 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.61417602 |
| 67 | AR_20517297_ChIP-Seq_VCAP_Human | 0.60940444 |
| 68 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.60242186 |
| 69 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.59143954 |
| 70 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.58514471 |
| 71 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.58212405 |
| 72 | CJUN_26792858_Chip-Seq_BT549_Human | 0.58026381 |
| 73 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.57643063 |
| 74 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.56609996 |
| 75 | NFYB_21822215_ChIP-Seq_K562_Human | 0.56333085 |
| 76 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.56078069 |
| 77 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.55641309 |
| 78 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.55431841 |
| 79 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.55257401 |
| 80 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.54762178 |
| 81 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.54373034 |
| 82 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.53940470 |
| 83 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.53351221 |
| 84 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.53107679 |
| 85 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.51550501 |
| 86 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.51283941 |
| 87 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.51015034 |
| 88 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.50665504 |
| 89 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.50665504 |
| 90 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.50337278 |
| 91 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.49265065 |
| 92 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.48776072 |
| 93 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.48555897 |
| 94 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.48364872 |
| 95 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.47971166 |
| 96 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.47865963 |
| 97 | TBL1_22424771_ChIP-Seq_293T_Human | 0.47861106 |
| 98 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.47728115 |
| 99 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.47612038 |
| 100 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.47220878 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 9.54595435 |
| 2 | MP0008875_abnormal_xenobiotic_pharmacok | 6.45959758 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.57326290 |
| 4 | MP0005365_abnormal_bile_salt | 5.37241340 |
| 5 | MP0005360_urolithiasis | 5.04167274 |
| 6 | MP0003195_calcinosis | 4.27349239 |
| 7 | MP0002138_abnormal_hepatobiliary_system | 4.08458626 |
| 8 | MP0003252_abnormal_bile_duct | 3.76402964 |
| 9 | MP0003191_abnormal_cellular_cholesterol | 3.32859162 |
| 10 | MP0003806_abnormal_nucleotide_metabolis | 3.09668084 |
| 11 | MP0001666_abnormal_nutrient_absorption | 2.94581363 |
| 12 | MP0010329_abnormal_lipoprotein_level | 2.76420618 |
| 13 | MP0005670_abnormal_white_adipose | 2.73165914 |
| 14 | MP0003868_abnormal_feces_composition | 2.69755332 |
| 15 | MP0009697_abnormal_copulation | 2.45821018 |
| 16 | MP0009840_abnormal_foam_cell | 2.44517591 |
| 17 | MP0005332_abnormal_amino_acid | 2.39538573 |
| 18 | MP0010368_abnormal_lymphatic_system | 2.00727472 |
| 19 | MP0000609_abnormal_liver_physiology | 1.93511210 |
| 20 | MP0002118_abnormal_lipid_homeostasis | 1.93425678 |
| 21 | MP0002876_abnormal_thyroid_physiology | 1.84328452 |
| 22 | MP0001764_abnormal_homeostasis | 1.74900412 |
| 23 | MP0002132_abnormal_respiratory_system | 1.60991526 |
| 24 | MP0004019_abnormal_vitamin_homeostasis | 1.36010816 |
| 25 | MP0002971_abnormal_brown_adipose | 1.31651584 |
| 26 | MP0005319_abnormal_enzyme/_coenzyme | 1.20050787 |
| 27 | MP0001661_extended_life_span | 1.17794495 |
| 28 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.13851829 |
| 29 | MP0009764_decreased_sensitivity_to | 1.07140982 |
| 30 | MP0003656_abnormal_erythrocyte_physiolo | 1.01132184 |
| 31 | MP0005408_hypopigmentation | 1.00275812 |
| 32 | MP0009643_abnormal_urine_homeostasis | 0.98824877 |
| 33 | MP0009763_increased_sensitivity_to | 0.98772708 |
| 34 | MP0005376_homeostasis/metabolism_phenot | 0.98557296 |
| 35 | MP0003186_abnormal_redox_activity | 0.98487410 |
| 36 | MP0005266_abnormal_metabolism | 0.96064268 |
| 37 | MP0000598_abnormal_liver_morphology | 0.94380641 |
| 38 | MP0006036_abnormal_mitochondrial_physio | 0.93620709 |
| 39 | MP0005334_abnormal_fat_pad | 0.90347346 |
| 40 | MP0009053_abnormal_anal_canal | 0.89342365 |
| 41 | MP0009642_abnormal_blood_homeostasis | 0.89180714 |
| 42 | MP0003011_delayed_dark_adaptation | 0.85829625 |
| 43 | MP0009115_abnormal_fat_cell | 0.84869532 |
| 44 | MP0004130_abnormal_muscle_cell | 0.80165245 |
| 45 | MP0005166_decreased_susceptibility_to | 0.79257399 |
| 46 | MP0008469_abnormal_protein_level | 0.78606141 |
| 47 | MP0002078_abnormal_glucose_homeostasis | 0.77894621 |
| 48 | MP0009785_altered_susceptibility_to | 0.77702034 |
| 49 | MP0005666_abnormal_adipose_tissue | 0.76713136 |
| 50 | MP0005535_abnormal_body_temperature | 0.73791005 |
| 51 | MP0005023_abnormal_wound_healing | 0.73637589 |
| 52 | MP0002282_abnormal_trachea_morphology | 0.72984329 |
| 53 | MP0000604_amyloidosis | 0.71674435 |
| 54 | MP0005187_abnormal_penis_morphology | 0.71586873 |
| 55 | MP0005636_abnormal_mineral_homeostasis | 0.69441082 |
| 56 | MP0002249_abnormal_larynx_morphology | 0.64247948 |
| 57 | MP0005395_other_phenotype | 0.63458122 |
| 58 | MP0008874_decreased_physiological_sensi | 0.60774178 |
| 59 | MP0003879_abnormal_hair_cell | 0.58086448 |
| 60 | MP0005464_abnormal_platelet_physiology | 0.55678641 |
| 61 | MP0005058_abnormal_lysosome_morphology | 0.55449418 |
| 62 | MP0008872_abnormal_physiological_respon | 0.55058022 |
| 63 | MP0001915_intracranial_hemorrhage | 0.54972283 |
| 64 | MP0002168_other_aberrant_phenotype | 0.53665056 |
| 65 | MP0005448_abnormal_energy_balance | 0.53129399 |
| 66 | MP0005451_abnormal_body_composition | 0.53108469 |
| 67 | MP0005083_abnormal_biliary_tract | 0.53053331 |
| 68 | MP0000749_muscle_degeneration | 0.52985713 |
| 69 | MP0002970_abnormal_white_adipose | 0.52627573 |
| 70 | MP0000249_abnormal_blood_vessel | 0.52461797 |
| 71 | MP0005330_cardiomyopathy | 0.51112409 |
| 72 | MP0002332_abnormal_exercise_endurance | 0.48717974 |
| 73 | MP0009765_abnormal_xenobiotic_induced | 0.48296052 |
| 74 | MP0003638_abnormal_response/metabolism_ | 0.47457695 |
| 75 | MP0005375_adipose_tissue_phenotype | 0.47238436 |
| 76 | MP0003959_abnormal_lean_body | 0.44659604 |
| 77 | MP0005164_abnormal_response_to | 0.44328553 |
| 78 | MP0002269_muscular_atrophy | 0.43724131 |
| 79 | MP0003690_abnormal_glial_cell | 0.42703204 |
| 80 | MP0005647_abnormal_sex_gland | 0.39748457 |
| 81 | MP0003705_abnormal_hypodermis_morpholog | 0.37884135 |
| 82 | MP0002136_abnormal_kidney_physiology | 0.37089038 |
| 83 | MP0009780_abnormal_chondrocyte_physiolo | 0.36142803 |
| 84 | MP0003953_abnormal_hormone_level | 0.35758544 |
| 85 | MP0004272_abnormal_basement_membrane | 0.34339572 |
| 86 | MP0005084_abnormal_gallbladder_morpholo | 0.34330364 |
| 87 | MP0000467_abnormal_esophagus_morphology | 0.30974346 |
| 88 | MP0006138_congestive_heart_failure | 0.30245117 |
| 89 | MP0003075_altered_response_to | 0.30091809 |
| 90 | MP0003950_abnormal_plasma_membrane | 0.29853199 |
| 91 | MP0001881_abnormal_mammary_gland | 0.28608136 |
| 92 | MP0002837_dystrophic_cardiac_calcinosis | 0.28546983 |
| 93 | MP0005452_abnormal_adipose_tissue | 0.26302973 |
| 94 | MP0010386_abnormal_urinary_bladder | 0.25268447 |
| 95 | MP0001845_abnormal_inflammatory_respons | 0.25076586 |
| 96 | MP0002128_abnormal_blood_circulation | 0.24700848 |
| 97 | MP0002295_abnormal_pulmonary_circulatio | 0.23653783 |
| 98 | MP0005397_hematopoietic_system_phenotyp | 0.23124721 |
| 99 | MP0001545_abnormal_hematopoietic_system | 0.23124721 |
| 100 | MP0000566_synostosis | 0.22935920 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 9.44818937 |
| 2 | Deep venous thrombosis (HP:0002625) | 9.13094174 |
| 3 | Abnormality of complement system (HP:0005339) | 9.03000316 |
| 4 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 8.70169434 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 8.30268062 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 7.13391703 |
| 7 | Systemic lupus erythematosus (HP:0002725) | 6.89963572 |
| 8 | Joint hemorrhage (HP:0005261) | 6.46863278 |
| 9 | Conjugated hyperbilirubinemia (HP:0002908) | 5.99969701 |
| 10 | Hyperlipoproteinemia (HP:0010980) | 5.82751226 |
| 11 | Spontaneous abortion (HP:0005268) | 5.50159917 |
| 12 | Glomerulonephritis (HP:0000099) | 5.28416651 |
| 13 | Xanthomatosis (HP:0000991) | 5.01283237 |
| 14 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.00024222 |
| 15 | Abnormality of pyrimidine metabolism (HP:0004353) | 4.62324895 |
| 16 | Abnormality of the intrinsic pathway (HP:0010989) | 4.60581186 |
| 17 | Abnormality of the common coagulation pathway (HP:0010990) | 4.57526810 |
| 18 | Intrahepatic cholestasis (HP:0001406) | 4.46117765 |
| 19 | Hypolipoproteinemia (HP:0010981) | 4.20827874 |
| 20 | Abnormality of methionine metabolism (HP:0010901) | 4.15284294 |
| 21 | Nephritis (HP:0000123) | 3.88966182 |
| 22 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.82709817 |
| 23 | Hyperglycinemia (HP:0002154) | 3.19286534 |
| 24 | Reduced antithrombin III activity (HP:0001976) | 3.18785793 |
| 25 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.16491291 |
| 26 | Gingival bleeding (HP:0000225) | 3.13800419 |
| 27 | Delayed CNS myelination (HP:0002188) | 3.04549638 |
| 28 | Hypoalphalipoproteinemia (HP:0003233) | 3.00536897 |
| 29 | Hypercholesterolemia (HP:0003124) | 2.95757988 |
| 30 | Hyperammonemia (HP:0001987) | 2.91026048 |
| 31 | Epidermoid cyst (HP:0200040) | 2.86245981 |
| 32 | Fat malabsorption (HP:0002630) | 2.82694657 |
| 33 | Generalized aminoaciduria (HP:0002909) | 2.75099414 |
| 34 | Abnormality of nucleobase metabolism (HP:0010932) | 2.74405016 |
| 35 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.73480533 |
| 36 | Abnormality of glycine metabolism (HP:0010895) | 2.69966743 |
| 37 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.69966743 |
| 38 | Thrombophlebitis (HP:0004418) | 2.68759496 |
| 39 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.63773883 |
| 40 | Hepatocellular carcinoma (HP:0001402) | 2.60649538 |
| 41 | Neonatal hypoglycemia (HP:0001998) | 2.52628079 |
| 42 | Purpura (HP:0000979) | 2.51411527 |
| 43 | Gout (HP:0001997) | 2.46060455 |
| 44 | Rickets (HP:0002748) | 2.43669764 |
| 45 | Hyperbilirubinemia (HP:0002904) | 2.43226284 |
| 46 | Steatorrhea (HP:0002570) | 2.43128487 |
| 47 | Ketosis (HP:0001946) | 2.31613805 |
| 48 | Hemorrhage of the eye (HP:0011885) | 2.24830374 |
| 49 | Hyperglycinuria (HP:0003108) | 2.21252434 |
| 50 | Abnormality of serum amino acid levels (HP:0003112) | 2.16332788 |
| 51 | Mitral stenosis (HP:0001718) | 2.14497428 |
| 52 | Osteomalacia (HP:0002749) | 2.13114144 |
| 53 | Metabolic acidosis (HP:0001942) | 2.12174668 |
| 54 | Pulmonary embolism (HP:0002204) | 2.06694293 |
| 55 | Joint swelling (HP:0001386) | 2.05816076 |
| 56 | Enlarged kidneys (HP:0000105) | 2.04423324 |
| 57 | Complement deficiency (HP:0004431) | 11.1105265 |
| 58 | Fair hair (HP:0002286) | 1.98480794 |
| 59 | Vascular calcification (HP:0004934) | 1.98038944 |
| 60 | Abnormal delivery (HP:0001787) | 1.95018619 |
| 61 | Abnormality of vitamin metabolism (HP:0100508) | 1.92603817 |
| 62 | Hyperphosphaturia (HP:0003109) | 1.91507611 |
| 63 | Abnormality of purine metabolism (HP:0004352) | 1.88275072 |
| 64 | Amyloidosis (HP:0011034) | 1.86020700 |
| 65 | Cerebral palsy (HP:0100021) | 1.85013022 |
| 66 | Increased serum ferritin (HP:0003281) | 1.84934003 |
| 67 | Skin nodule (HP:0200036) | 1.84875317 |
| 68 | Atrioventricular block (HP:0001678) | 1.80951223 |
| 69 | Abnormality of iron homeostasis (HP:0011031) | 1.80708238 |
| 70 | Menorrhagia (HP:0000132) | 1.75955817 |
| 71 | Cardiovascular calcification (HP:0011915) | 1.73733297 |
| 72 | Impaired platelet aggregation (HP:0003540) | 1.71629209 |
| 73 | Abnormal platelet function (HP:0011869) | 1.71629209 |
| 74 | Cholelithiasis (HP:0001081) | 1.70047637 |
| 75 | Irritability (HP:0000737) | 1.68956448 |
| 76 | Elevated alkaline phosphatase (HP:0003155) | 1.66797292 |
| 77 | Abnormality of urine glucose concentration (HP:0011016) | 1.66756107 |
| 78 | Glycosuria (HP:0003076) | 1.66756107 |
| 79 | Facial shape deformation (HP:0011334) | 1.63854493 |
| 80 | Potter facies (HP:0002009) | 1.63854493 |
| 81 | Increased mean platelet volume (HP:0011877) | 1.62814367 |
| 82 | Gangrene (HP:0100758) | 1.61811901 |
| 83 | Epistaxis (HP:0000421) | 1.60785563 |
| 84 | Abnormal gallbladder morphology (HP:0012437) | 1.59746097 |
| 85 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.59361419 |
| 86 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.59047741 |
| 87 | Pancreatitis (HP:0001733) | 1.56653716 |
| 88 | Hypertriglyceridemia (HP:0002155) | 1.56438392 |
| 89 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.54914215 |
| 90 | Protuberant abdomen (HP:0001538) | 1.54057501 |
| 91 | Increased serum pyruvate (HP:0003542) | 1.53761132 |
| 92 | Poikilocytosis (HP:0004447) | 1.53616647 |
| 93 | Back pain (HP:0003418) | 1.49065947 |
| 94 | Abnormal urine phosphate concentration (HP:0012599) | 1.48659114 |
| 95 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.44470987 |
| 96 | Lethargy (HP:0001254) | 1.44375697 |
| 97 | Bifid scrotum (HP:0000048) | 1.43993951 |
| 98 | Abnormal platelet volume (HP:0011876) | 1.43729122 |
| 99 | Abnormal tarsal ossification (HP:0008369) | 1.42772927 |
| 100 | Dicarboxylic aciduria (HP:0003215) | 1.39925436 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PINK1 | 6.40216453 |
| 2 | ERN1 | 3.33449682 |
| 3 | OBSCN | 3.30927198 |
| 4 | ARAF | 3.26989268 |
| 5 | MST1R | 3.21376479 |
| 6 | MAP3K13 | 2.81658576 |
| 7 | PIK3CG | 2.55018502 |
| 8 | MAP3K9 | 2.41178083 |
| 9 | RIPK1 | 2.40403719 |
| 10 | TRIB3 | 2.31522681 |
| 11 | EPHA3 | 2.10697920 |
| 12 | MARK3 | 2.09638394 |
| 13 | FGFR4 | 2.05057092 |
| 14 | EPHB1 | 2.04070754 |
| 15 | MYLK | 2.01467318 |
| 16 | MAP3K1 | 1.97257237 |
| 17 | MAP3K3 | 1.90068853 |
| 18 | NLK | 1.62071687 |
| 19 | SIK1 | 1.58079946 |
| 20 | LATS1 | 1.53141160 |
| 21 | TYK2 | 1.52378582 |
| 22 | MAPK15 | 1.46330308 |
| 23 | TIE1 | 1.40129130 |
| 24 | MOS | 1.36608159 |
| 25 | PRKAA2 | 1.34411014 |
| 26 | PIK3CA | 1.29284785 |
| 27 | PRKACG | 1.22718421 |
| 28 | MAP3K2 | 1.18170450 |
| 29 | PKN2 | 1.15010050 |
| 30 | KSR2 | 1.14265019 |
| 31 | BCKDK | 1.12740984 |
| 32 | MET | 1.11487410 |
| 33 | PDPK1 | 1.10751220 |
| 34 | JAK1 | 1.08957039 |
| 35 | TGFBR2 | 1.07902578 |
| 36 | LMTK2 | 1.06870407 |
| 37 | TRPM7 | 1.06841380 |
| 38 | MAP2K4 | 1.05037622 |
| 39 | ABL2 | 1.00782344 |
| 40 | MAPKAPK3 | 0.99371909 |
| 41 | STK38L | 0.98478695 |
| 42 | MAPK12 | 0.95625708 |
| 43 | IGF1R | 0.94076352 |
| 44 | LATS2 | 0.90210012 |
| 45 | EPHA2 | 0.88932758 |
| 46 | MAP3K12 | 0.86774853 |
| 47 | RET | 0.85585546 |
| 48 | PRPF4B | 0.84750766 |
| 49 | FGFR3 | 0.80499773 |
| 50 | TBK1 | 0.78977806 |
| 51 | NME2 | 0.78128227 |
| 52 | CAMKK2 | 0.77704323 |
| 53 | MUSK | 0.76951418 |
| 54 | FER | 0.74702524 |
| 55 | MAPK11 | 0.69494973 |
| 56 | PRKG1 | 0.68826743 |
| 57 | MAP3K7 | 0.67720928 |
| 58 | SGK494 | 0.67464093 |
| 59 | SGK223 | 0.67464093 |
| 60 | MAP3K6 | 0.66019795 |
| 61 | PDK1 | 0.65910647 |
| 62 | NEK9 | 0.63287929 |
| 63 | BLK | 0.62373579 |
| 64 | TNK2 | 0.59012792 |
| 65 | EIF2AK3 | 0.56989522 |
| 66 | PRKAA1 | 0.56575915 |
| 67 | MAP2K7 | 0.56017491 |
| 68 | ICK | 0.55778203 |
| 69 | RAF1 | 0.53457211 |
| 70 | EIF2AK1 | 0.53152117 |
| 71 | BRAF | 0.53048557 |
| 72 | SGK3 | 0.51655626 |
| 73 | AKT2 | 0.51463356 |
| 74 | SGK2 | 0.50693161 |
| 75 | PRKG2 | 0.49659115 |
| 76 | CAMK2G | 0.49623310 |
| 77 | JAK2 | 0.48505266 |
| 78 | SCYL2 | 0.46068490 |
| 79 | INSRR | 0.45405934 |
| 80 | MAP3K5 | 0.44271832 |
| 81 | PRKACA | 0.44022545 |
| 82 | PRKACB | 0.42822124 |
| 83 | EEF2K | 0.41776081 |
| 84 | STK38 | 0.41535221 |
| 85 | KDR | 0.40013127 |
| 86 | ZAP70 | 0.39695322 |
| 87 | BRSK2 | 0.39551492 |
| 88 | GRK5 | 0.39084715 |
| 89 | PRKCQ | 0.38638421 |
| 90 | IRAK3 | 0.36959858 |
| 91 | ILK | 0.35908481 |
| 92 | MAPK4 | 0.35266459 |
| 93 | MAPK7 | 0.33143550 |
| 94 | MAP2K3 | 0.32112725 |
| 95 | PRKCZ | 0.30530780 |
| 96 | MTOR | 0.29426875 |
| 97 | ERBB2 | 0.28429814 |
| 98 | PRKCG | 0.27906151 |
| 99 | CAMKK1 | 0.27041606 |
| 100 | ROCK1 | 0.26563248 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 5.12601357 |
| 2 | Caffeine metabolism_Homo sapiens_hsa00232 | 4.18655953 |
| 3 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 4.02300272 |
| 4 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.84041356 |
| 5 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 3.25429074 |
| 6 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 3.22237830 |
| 7 | Retinol metabolism_Homo sapiens_hsa00830 | 3.16990579 |
| 8 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.84922962 |
| 9 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.77903686 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.68605580 |
| 11 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.64447360 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.45031903 |
| 13 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.44917701 |
| 14 | Tyrosine metabolism_Homo sapiens_hsa00350 | 2.42720198 |
| 15 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.34292542 |
| 16 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.25518380 |
| 17 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.23304629 |
| 18 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.22878854 |
| 19 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.01755118 |
| 20 | Histidine metabolism_Homo sapiens_hsa00340 | 1.89761978 |
| 21 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.85840980 |
| 22 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.74866779 |
| 23 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.67155131 |
| 24 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.58557790 |
| 25 | Bile secretion_Homo sapiens_hsa04976 | 1.57305325 |
| 26 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.52658025 |
| 27 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.51586306 |
| 28 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.50234170 |
| 29 | Prion diseases_Homo sapiens_hsa05020 | 1.48943002 |
| 30 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.47658332 |
| 31 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.45554349 |
| 32 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.44410229 |
| 33 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.37300084 |
| 34 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.31051213 |
| 35 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.27316315 |
| 36 | Peroxisome_Homo sapiens_hsa04146 | 1.25521889 |
| 37 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.22379043 |
| 38 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.20130939 |
| 39 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.13507136 |
| 40 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.06418033 |
| 41 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.96865796 |
| 42 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.96229770 |
| 43 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.91642963 |
| 44 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.87052307 |
| 45 | Carbon metabolism_Homo sapiens_hsa01200 | 0.87009942 |
| 46 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.86979954 |
| 47 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.86324800 |
| 48 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.84687954 |
| 49 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.84157117 |
| 50 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.71212991 |
| 51 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.70764248 |
| 52 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.61918237 |
| 53 | ABC transporters_Homo sapiens_hsa02010 | 0.59709324 |
| 54 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.58438523 |
| 55 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.57387651 |
| 56 | Sulfur relay system_Homo sapiens_hsa04122 | 0.44428989 |
| 57 | Pertussis_Homo sapiens_hsa05133 | 0.43297393 |
| 58 | Metabolic pathways_Homo sapiens_hsa01100 | 0.42695653 |
| 59 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.40648872 |
| 60 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.40592263 |
| 61 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.39067361 |
| 62 | Lysine degradation_Homo sapiens_hsa00310 | 0.34770779 |
| 63 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.32190078 |
| 64 | Insulin resistance_Homo sapiens_hsa04931 | 0.28923950 |
| 65 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.26775789 |
| 66 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.23718163 |
| 67 | Mineral absorption_Homo sapiens_hsa04978 | 0.22813922 |
| 68 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.18467060 |
| 69 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.17629985 |
| 70 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.17076294 |
| 71 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.17033922 |
| 72 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.16280830 |
| 73 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.14861950 |
| 74 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.08769123 |
| 75 | Amoebiasis_Homo sapiens_hsa05146 | 0.07919200 |
| 76 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.07059643 |
| 77 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.05882944 |
| 78 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.05782640 |
| 79 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.2378675 |
| 80 | FoxO signaling pathway_Homo sapiens_hsa04068 | -0.2173698 |
| 81 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.2155577 |
| 82 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.2002900 |
| 83 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1901533 |
| 84 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.1868188 |
| 85 | Nitrogen metabolism_Homo sapiens_hsa00910 | -0.1829959 |
| 86 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | -0.1779796 |
| 87 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.1687747 |
| 88 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | -0.1542303 |
| 89 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1521138 |
| 90 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1047802 |
| 91 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.0913445 |
| 92 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | -0.0745583 |
| 93 | Selenocompound metabolism_Homo sapiens_hsa00450 | -0.0688024 |
| 94 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.0686292 |
| 95 | Other glycan degradation_Homo sapiens_hsa00511 | -0.0582996 |
| 96 | Circadian rhythm_Homo sapiens_hsa04710 | -0.0552573 |
| 97 | Galactose metabolism_Homo sapiens_hsa00052 | -0.0451451 |
| 98 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0368586 |
| 99 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0310142 |
| 100 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | -0.0056374 |

